ProfileGDS4718 / 231887_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 59% 63% 78% 61% 63% 90% 92% 61% 69% 68% 63% 68% 70% 89% 90% 58% 63% 91% 86% 87% 63% 59% 61% 65% 65% 89% 62% 92% 58% 93% 66% 93% 66% 60% 91% 91% 80% 65% 67% 83% 63% 83% 93% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0896259
GSM549102patient 115, normal, homogenized [OPG study]6.3217963
GSM549104patient 119, normal, homogenized [OPG study]7.7033278
GSM549108patient 138, normal, homogenized [OPG study]6.2224561
GSM549119patient 077, normal, homogenized [OPG study]6.3653963
GSM549133patient 032, cancer, homogenized [OPG study]9.2947590
GSM549139patient 042, cancer, homogenized [OPG study]9.5442292
GSM549099patient 107, normal, homogenized [OPG study]6.1950661
GSM549109patient 139, normal, homogenized [OPG study]6.7848569
GSM549110patient 046, normal, homogenized [OPG study]6.6778768
GSM549114patient 063, normal, homogenized [OPG study]6.2656163
GSM549122patient 082, normal, homogenized [OPG study]6.7419368
GSM549134patient 033, cancer, homogenized [OPG study]6.8640470
GSM549136patient 036, cancer, homogenized [OPG study]9.1606289
GSM549140patient 044, cancer, homogenized [OPG study]9.2607390
GSM549111patient 047, normal, homogenized [OPG study]6.0137458
GSM549113patient 057, normal, homogenized [OPG study]6.3039463
GSM549132patient 031, cancer, homogenized [OPG study]9.2507991
GSM549137patient 038, cancer, homogenized [OPG study]8.6451186
GSM549142patient 047, cancer, homogenized [OPG study]8.3610687
GSM549100patient 110, normal, homogenized [OPG study]6.2954463
GSM549107patient 135, normal, homogenized [OPG study]6.0153259
GSM549115patient 068, normal, homogenized [OPG study]6.1640461
GSM549116patient 072, normal, homogenized [OPG study]6.47965
GSM549120patient 078, normal, homogenized [OPG study]6.5060165
GSM549131patient 030, cancer, homogenized [OPG study]9.1469489
GSM549118patient 074, normal, homogenized [OPG study]6.2474662
GSM549129patient 027, cancer, homogenized [OPG study]9.3320892
GSM549123patient 088, normal, homogenized [OPG study]5.9792758
GSM549124patient 006, cancer, homogenized [OPG study]9.533793
GSM549126patient 015, cancer, homogenized [OPG study]6.585666
GSM549128patient 025, cancer, homogenized [OPG study]9.8282193
GSM549103patient 117, normal, homogenized [OPG study]6.5010866
GSM549117patient 073, normal, homogenized [OPG study]6.0906360
GSM549138patient 041, cancer, homogenized [OPG study]9.282991
GSM549141patient 045, cancer, homogenized [OPG study]9.452591
GSM549130patient 028, cancer, homogenized [OPG study]7.8042880
GSM549101patient 111, normal, homogenized [OPG study]6.4924965
GSM549105patient 128, normal, homogenized [OPG study]6.6571967
GSM549106patient 134, normal, homogenized [OPG study]8.3979383
GSM549112patient 048, normal, homogenized [OPG study]6.3429263
GSM549125patient 011, cancer, homogenized [OPG study]8.1773883
GSM549127patient 024, cancer, homogenized [OPG study]9.5888993
GSM549135patient 035, cancer, homogenized [OPG study]10.58296